TY - JOUR
T1 - Retrospective analysis of changing characteristics of treatment-seeking smokers
T2 - Implications for further reducing smoking prevalence
AU - Leyro, Teresa M.
AU - Crew, Erin E.
AU - Bryson, Susan W.
AU - Lembke, Anna
AU - Bailey, Steffani R.
AU - Prochaska, Judith J.
AU - Henriksen, Lisa
AU - Fortmann, Stephen P.
AU - Killen, Joel D.
AU - Killen, Diana T.
AU - Hall, Sharon M.
AU - David, Sean P.
N1 - Funding Information:
This work was supported by the University of California Tobacco-Related Disease Research Program, grant numbers RT 0041 and 21BT-0018, the National Cancer Institute, grant number CA 090300 and the National Institute on Drug Abuse, grant numbers R0I DA 017441, R0I DA 017457, P50 DA009253, K05DA016752, R01 DA02538 and T32DA007250.
PY - 2016/6/1
Y1 - 2016/6/1
N2 - Objective: The goal of the current study was to empirically compare successive cohorts of treatmentseeking smokers who enrolled in randomised clinical trials in a region of the USA characterised by strong tobacco control policies and low smoking prevalence, over the past three decades. Design: Retrospective treatment cohort comparison. Setting: Data were collected from 9 randomised clinical trials conducted at Stanford University and the University of California, San Francisco, between 1990 and 2013. Participants: Data from a total of 2083 participants were included (Stanford, n=1356; University of California San Francisco, n=727). Primary and secondary outcomes: One-way analysis of variance and covariance, χ2 and logistic regression analyses were used to examine relations between nicotine dependence, cigarettes per day, depressive symptoms and demographic characteristics among study cohorts. Results: Similar trends were observed at both settings. When compared to earlier trials, participants in more recent trials smoked fewer cigarettes, were less nicotine-dependent, reported more depressive symptoms, were more likely to be male and more likely to be from a minority ethnic/racial group, than those enrolled in initial trials (all p's<0.05). Analysis of covariances revealed that cigarettes per day, nicotine dependence and current depressive symptom scores were each significantly related to trial (all p's<0.001). Conclusions: Our findings suggest that more recent smoking cessation treatment-seeking cohorts in a low prevalence region were characterised by less smoking severity, more severe symptoms of depression and were more likely to be male and from a minority racial/ethnic group.
AB - Objective: The goal of the current study was to empirically compare successive cohorts of treatmentseeking smokers who enrolled in randomised clinical trials in a region of the USA characterised by strong tobacco control policies and low smoking prevalence, over the past three decades. Design: Retrospective treatment cohort comparison. Setting: Data were collected from 9 randomised clinical trials conducted at Stanford University and the University of California, San Francisco, between 1990 and 2013. Participants: Data from a total of 2083 participants were included (Stanford, n=1356; University of California San Francisco, n=727). Primary and secondary outcomes: One-way analysis of variance and covariance, χ2 and logistic regression analyses were used to examine relations between nicotine dependence, cigarettes per day, depressive symptoms and demographic characteristics among study cohorts. Results: Similar trends were observed at both settings. When compared to earlier trials, participants in more recent trials smoked fewer cigarettes, were less nicotine-dependent, reported more depressive symptoms, were more likely to be male and more likely to be from a minority ethnic/racial group, than those enrolled in initial trials (all p's<0.05). Analysis of covariances revealed that cigarettes per day, nicotine dependence and current depressive symptom scores were each significantly related to trial (all p's<0.001). Conclusions: Our findings suggest that more recent smoking cessation treatment-seeking cohorts in a low prevalence region were characterised by less smoking severity, more severe symptoms of depression and were more likely to be male and from a minority racial/ethnic group.
UR - http://www.scopus.com/inward/record.url?scp=84978091892&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84978091892&partnerID=8YFLogxK
U2 - 10.1136/bmjopen-2015-010960
DO - 10.1136/bmjopen-2015-010960
M3 - Article
C2 - 27357195
AN - SCOPUS:84978091892
SN - 2044-6055
VL - 6
JO - BMJ Open
JF - BMJ Open
IS - 6
M1 - 010960
ER -